|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,565.00 ARS | -1.88% |
|
-1.57% | -20.76% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.51 | 4.11 | 2.35 | 3.26 | 4.9 | |||||
Return on Total Capital | 11.77 | 5.78 | 3.07 | 4.19 | 6.09 | |||||
Return On Equity % | 11.37 | 1.54 | -39.9 | 41.29 | 2.39 | |||||
Return on Common Equity | 11.38 | 1.6 | -40.21 | 42.05 | 2.73 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.33 | 47.97 | 52.04 | 54.73 | 61.91 | |||||
SG&A Margin | 15.19 | 29.94 | 38.46 | 35.92 | 36.96 | |||||
EBITDA Margin % | 14.96 | 18.01 | 16.5 | 19.88 | 26.04 | |||||
EBITA Margin % | 13.98 | 16.15 | 13.58 | 16.96 | 23.6 | |||||
EBIT Margin % | 13.98 | 16.15 | 13.58 | 16.96 | 23.6 | |||||
Income From Continuing Operations Margin % | 3.62 | 0.86 | -28 | 25.94 | 1.69 | |||||
Net Income Margin % | 3.56 | 0.88 | -27.8 | 25.98 | 2.44 | |||||
Net Avail. For Common Margin % | 3.56 | 0.88 | -27.8 | 25.98 | 1.9 | |||||
Normalized Net Income Margin | 2.55 | 1.66 | -16.46 | 21.13 | 7.73 | |||||
Levered Free Cash Flow Margin | -13.41 | -52.46 | 6.61 | -6.19 | -41.66 | |||||
Unlevered Free Cash Flow Margin | -10.61 | -47.62 | 15.11 | -3.96 | -34.28 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.86 | 0.41 | 0.28 | 0.31 | 0.33 | |||||
Fixed Assets Turnover | 3.02 | 0.99 | 0.46 | 0.49 | 0.56 | |||||
Receivables Turnover (Average Receivables) | 4.24 | 3.17 | 2.99 | 3.48 | 2.65 | |||||
Inventory Turnover (Average Inventory) | 3.7 | 1.52 | 1.17 | 1.39 | 1.29 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.66 | 1.55 | 0.86 | 1.21 | 1.01 | |||||
Quick Ratio | 1.2 | 0.92 | 0.4 | 0.74 | 0.65 | |||||
Operating Cash Flow to Current Liabilities | 0.4 | -0.47 | -0.07 | 0.1 | 0.02 | |||||
Days Sales Outstanding (Average Receivables) | 86.14 | 114.98 | 121.97 | 105.11 | 137.7 | |||||
Days Outstanding Inventory (Average Inventory) | 98.55 | 239.77 | 311.17 | 263.26 | 283.78 | |||||
Average Days Payable Outstanding | 130.63 | 396.42 | 383.54 | 451.29 | 262.73 | |||||
Cash Conversion Cycle (Average Days) | 54.05 | -41.66 | 49.61 | -82.92 | 158.75 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 213.63 | 209.94 | 410.21 | 219.76 | 264.82 | |||||
Total Debt / Total Capital | 68.12 | 67.74 | 80.4 | 68.73 | 72.59 | |||||
LT Debt/Equity | 179.67 | 181.45 | 368.1 | 191.34 | 200.54 | |||||
Long-Term Debt / Total Capital | 57.29 | 58.54 | 72.15 | 59.84 | 54.97 | |||||
Total Liabilities / Total Assets | 79.08 | 74.91 | 85.18 | 74.88 | 77.86 | |||||
EBIT / Interest Expense | 3.12 | 2.08 | 1 | 4.73 | 2 | |||||
EBITDA / Interest Expense | 3.39 | 2.37 | 1.24 | 5.57 | 2.27 | |||||
(EBITDA - Capex) / Interest Expense | -3.72 | -2.3 | -0.53 | 4.13 | -0.26 | |||||
Total Debt / EBITDA | 4.55 | 6.31 | 14.31 | 7.84 | 7.26 | |||||
Net Debt / EBITDA | 1.71 | 5.56 | 14.19 | 7.3 | 6.81 | |||||
Total Debt / (EBITDA - Capex) | -4.14 | -6.52 | -33.31 | 10.57 | -63.83 | |||||
Net Debt / (EBITDA - Capex) | -1.56 | -5.74 | -33.02 | 9.84 | -59.86 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 78.08 | -42.93 | -32.15 | 8.01 | 4.95 | |||||
Gross Profit, 1 Yr. Growth % | 10.82 | -7.73 | -25.27 | 12.24 | 19.22 | |||||
EBITDA, 1 Yr. Growth % | -3.79 | -35.6 | -44.09 | 9.8 | 11.98 | |||||
EBITA, 1 Yr. Growth % | -2.79 | -37.48 | -48.21 | 12.49 | 15.69 | |||||
EBIT, 1 Yr. Growth % | -0.26 | -33.6 | -42.67 | 34.89 | 50.28 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -18.01 | -86.39 | -2.3K | -200.07 | -93.17 | |||||
Net Income, 1 Yr. Growth % | -19.41 | -85.81 | -2.23K | -200.91 | -90.16 | |||||
Normalized Net Income, 1 Yr. Growth % | -41.35 | -61.91 | -793.41 | -205.05 | -33.84 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -19.47 | -85.84 | -2.23K | -200.91 | -92.34 | |||||
Accounts Receivable, 1 Yr. Growth % | -18.03 | -30.89 | -23.87 | 14.73 | 58.03 | |||||
Inventory, 1 Yr. Growth % | 57.61 | -30.52 | -2.01 | -26.19 | 24.76 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 162.24 | 40.27 | 48.82 | -27.92 | 18.08 | |||||
Total Assets, 1 Yr. Growth % | 98.6 | -18.64 | 22.16 | -22.88 | 22.81 | |||||
Tangible Book Value, 1 Yr. Growth % | 4.74 | -2.84 | -31.32 | 42.7 | 8.37 | |||||
Common Equity, 1 Yr. Growth % | 3.74 | -2.15 | -28.24 | 30.94 | 8.17 | |||||
Cash From Operations, 1 Yr. Growth % | -2.16K | -158.92 | -81.22 | -223.73 | -74.77 | |||||
Capital Expenditures, 1 Yr. Growth % | 843.51 | -35.18 | -54.85 | -76.93 | 507.97 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 68.6 | 32.15 | -107.73 | -69.31 | 291.89 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 75.34 | 36.89 | -119.29 | -46.82 | 454.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 77.01 | 40.7 | 9.81 | 26.33 | 22.11 | |||||
Gross Profit, 2 Yr. CAGR % | 39.9 | 39.59 | 45.44 | 35.96 | 32.4 | |||||
EBITDA, 2 Yr. CAGR % | 41.07 | 13.47 | 11.68 | 25.85 | 40.91 | |||||
EBITA, 2 Yr. CAGR % | 45.09 | 11.73 | 5.4 | 23.34 | 47.02 | |||||
EBIT, 2 Yr. CAGR % | 47.82 | 13.17 | 8.61 | 29.77 | 60.99 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 87.57 | -53.38 | 205.39 | 592.62 | -70.01 | |||||
Net Income, 2 Yr. CAGR % | 93.16 | -52.81 | 206.89 | 584.49 | -63.85 | |||||
Normalized Net Income, 2 Yr. CAGR % | 74.55 | -34.84 | 182.57 | 357.54 | -27.18 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 93.25 | -52.86 | 206.86 | 584.63 | -68.1 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.57 | 5.05 | 28 | 37.92 | 54.44 | |||||
Inventory, 2 Yr. CAGR % | 73.72 | 46.05 | 45.61 | 25.49 | 10.06 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 121.3 | 167.69 | 154.97 | 52.84 | 5.81 | |||||
Total Assets, 2 Yr. CAGR % | 91.72 | 77.41 | 75.93 | 43.23 | 11.62 | |||||
Tangible Book Value, 2 Yr. CAGR % | 39.43 | 40.79 | 44.15 | 46.08 | 42.63 | |||||
Common Equity, 2 Yr. CAGR % | 37.72 | 40.62 | 47.88 | 43.05 | 36.5 | |||||
Cash From Operations, 2 Yr. CAGR % | 455.47 | 386.14 | -41.31 | -35.09 | -35.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | 274.02 | 245.15 | -4.53 | -52.37 | 35.84 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 151.96 | 170.75 | -40.69 | -58.71 | 68.81 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 176.39 | 195.76 | -4.2 | -65.54 | 152.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 81.15 | 51.58 | 61.12 | 41.55 | 30.12 | |||||
Gross Profit, 3 Yr. CAGR % | 59.65 | 50.98 | 64.69 | 73.6 | 42.38 | |||||
EBITDA, 3 Yr. CAGR % | 113.72 | 38.61 | 35.6 | 52.31 | 42.01 | |||||
EBITA, 3 Yr. CAGR % | 131.46 | 39.31 | 30.41 | 48.32 | 42.99 | |||||
EBIT, 3 Yr. CAGR % | 137.74 | 41.05 | 31.53 | 51.33 | 47.91 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.25 | -2.31 | 146.05 | 172.9 | 62.74 | |||||
Net Income, 3 Yr. CAGR % | 21.27 | 1.02 | 145.43 | 174.56 | 82.39 | |||||
Normalized Net Income, 3 Yr. CAGR % | 27.78 | 30.17 | 107.23 | 188.87 | 119.45 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 21.22 | 1.01 | 145.42 | 174.54 | 67.81 | |||||
Accounts Receivable, 3 Yr. CAGR % | 49.84 | 23 | 37.79 | 59.97 | 58.13 | |||||
Inventory, 3 Yr. CAGR % | 67.33 | 59.85 | 86.71 | 50.48 | 37.24 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 138.13 | 137.41 | 221.43 | 116.9 | 53.67 | |||||
Total Assets, 3 Yr. CAGR % | 83.45 | 79.93 | 128.78 | 73.23 | 49.1 | |||||
Tangible Book Value, 3 Yr. CAGR % | 50.62 | 54.38 | 61.85 | 86.21 | 44.9 | |||||
Common Equity, 3 Yr. CAGR % | 48.48 | 53.48 | 64.1 | 84.06 | 42.8 | |||||
Cash From Operations, 3 Yr. CAGR % | 173.68 | 228.39 | 139.97 | -8.22 | -48.1 | |||||
Capital Expenditures, 3 Yr. CAGR % | 179.03 | 160.43 | 155.86 | -22.92 | 21.96 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 59.02 | 202.22 | 24.97 | -8.13 | 16.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 53.77 | 236.53 | 80.34 | -17.32 | 12.43 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 80.97 | 63.28 | 69.43 | 76.87 | 68.5 | |||||
Gross Profit, 5 Yr. CAGR % | 60.92 | 62.4 | 74.98 | 81.16 | 76.76 | |||||
EBITDA, 5 Yr. CAGR % | 58.7 | 68.12 | 90.82 | 70.97 | 66.44 | |||||
EBITA, 5 Yr. CAGR % | 57.56 | 69.94 | 95.13 | 69.78 | 65.77 | |||||
EBIT, 5 Yr. CAGR % | 57.56 | 72.31 | 98.3 | 71.06 | 66.62 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 44.7 | 26.75 | 99.48 | 168.4 | 23.88 | |||||
Net Income, 5 Yr. CAGR % | 44.22 | 27.39 | 100.89 | 172.56 | 33.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 35.11 | 36.67 | 99.57 | 168.51 | 68.45 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.05 | 19.76 | 100.86 | 172.65 | 26.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | 48.56 | 47.79 | 60.76 | 61.61 | 68.51 | |||||
Inventory, 5 Yr. CAGR % | 82.33 | 61.19 | 80.86 | 82.11 | 76.59 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 167.43 | 140.67 | 179.64 | 149.84 | 140.8 | |||||
Total Assets, 5 Yr. CAGR % | 97.22 | 73.67 | 106.14 | 106.13 | 100.61 | |||||
Tangible Book Value, 5 Yr. CAGR % | 109.18 | 52.01 | 69.11 | 89.52 | 79.78 | |||||
Common Equity, 5 Yr. CAGR % | 103.92 | 51.76 | 69.38 | 87.28 | 78.12 | |||||
Cash From Operations, 5 Yr. CAGR % | 299.46 | 228.66 | 68.93 | 115.49 | 59.4 | |||||
Capital Expenditures, 5 Yr. CAGR % | 245 | 144.41 | 107.61 | 65.66 | 132.07 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 129.7 | 126.64 | 36.01 | 74.54 | 109.07 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 175.49 | 136.96 | 64.82 | 73.53 | 112.38 |
- Stock Market
- Stocks
- RICH Stock
- Financials Laboratorios Richmond S.A.C.I.F.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















